Attorney General Jackley Addresses Research and Development for Medical Marijuana Derivatives with the FDA and DEA

Pat Powers

jackleyheader2 Marty JackleyAttorney General Jackley Addresses Research and Development for Medical Marijuana Derivatives with the FDA and DEA

PIERRE, S.D. – Attorney General Marty Jackley continues to work with the FDA and DEA to address research and development for medical marijuana and its derivatives.

“As Attorney General, I am hopeful that research will conclude marijuana derivatives will help treat a child experiencing seizures or the pain of a cancer patient. I am urging the FDA and DEA to consider accelerated research of marijuana for treatment purposes. If marijuana is determined to provide a medical benefit, I believe safeguards for public health and safety can be put in place which include FDA approval, a South Dakota doctor prescribing the drug, and a South Dakota pharmacist dispensing the drug,” said Attorney General Jackley.

On August 19, 2016, Attorney General Jackley provided correspondence to the DEA and FDA urging consideration of an accelerated research and development process for marijuana derivatives. While Attorney General Jackley made clear he was not endorsing a particular area of research or marijuana use, he believes that the public health aspect justifies both the DEA and the FDA revisiting the research restrictions   as it relates to marijuana with an eye towards medical research in a controlled environment.

The DEA response on October 13, 2016, outlined several steps that have been taken to address the FDA approval process including with Cannabidiol (CBD). The DEA set forth that “while the DEA shares your desire to facilitate research with CBD, and to carry out any scheduling actions that are supported by the medical and scientific evidence, as you undoubtedly recognize the protection of the public health and safety must remain of paramount  consideration.”

Attorney General Jackley agrees and believes three important conditions must be satisfied for public health and safety reasons: 1) FDA approval for marijuana or one or more of the derivatives as a safe and effective drug; 2) A South Dakota doctor to prescribe the drug; and 3) A South Dakota pharmacist to dispense the drug.

In December 2015, the DEA adopted a new policy to waive certain regulatory requirements to those who are conducting research with CBD to include those conducting trials with CBD no longer have to request approval from the DEA before implementing changes to their research protocols.

In August 2016, the DEA adopted a new policy whereby additional entities may apply to become registered to grow marijuana for the purpose of supplying researchers. In addition, the DEA continues to assess the current regulatory requirements for conducting research with CBD to determine whether it can take further steps to reduce the regulatory burden while continuing to protect the public health and safety.

The DEA recognizes the possibility that drugs containing CBD might be proven to be safe and effective for the treatment of certain conditions and with FDA approval for marketing. The DEA closed the correspondence with their assurance they will strive to make it easier for research while keeping the public  safe.

Links to letters below:

http://stage7.atg.sd.gov/docs/Medical%20Marijuana.DEA.pdf

-30-

16 thoughts on “Attorney General Jackley Addresses Research and Development for Medical Marijuana Derivatives with the FDA and DEA”

  2. The one thing I know for sure about medicine, is we don’t know it all.

    There are constantly new medicines, new procedures, new information and some of the old techniques still work. We would be fools to not research a possible drug.

    Attorney General Jackley wants to put in place some common sense protections. I can support this

  4. Once California legalizes what Jackley does or press releases will be irrelevant. The entire west coast will have legalized the evil weed and the rest of the states will come to their senses and do the same. Resistance is futile.

  5. We all are forgetting a couple things Our AG knows well. One the Feds could at any time break into any of the State sponsored State legalized Marijuana growing facilities or shops anywhere in the Country at Their leisure citing Class One status and arrest everyone involved.
    Two the Marijuana legalization freight train has left the station and is headed straight towards South Dakota knowing full well we need to get involved in this now instead of later.

  7. Hey look another press release from AG Jackley. Does he have a full time Twitter person to let us know his every move or is that what his press release person is for?

  8. Marty has one of South Dakota’s three electoral votes and I think we should I demand to know where he stands on Trump.

    1. You don’t have to worry. Jackley would never do anything that would jeopardize his political career, regardless of what he personally thinks.

  10. “The Public”,

    I don’t demand he say anything and I’m part of the public and voting for Trump. I generally live by the maxim “don’t ask a question where the answer won’t change anything I will do or think” lest I become distracted by stuff which doesn’t matter.

    Why do you demand him to “take a stand? What will you do different based on the answer? Maybe your answers will change my mind.

  12. Thanks for the advice Porter but I’ve never worried about the effect of my political views/comments on my personal or professional reputation. What is best for the country is my primary concern. If I did, I wouldn’t post (anonymously or otherwise).

Comments are closed.